🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01399125
This study used two doses of rivastigmine transdermal patch (5 cm\^2, 10 cm...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-09
Trial ID
NCT00549601
The purpose of this study is to assess the safety and efficacy of masitinib...
Status
Completed
Location
MHAT Sveta Marina
Start Date
2012-01
Trial ID
NCT01872598
Treatments Being Tested
The purpose of this multicenter trial is to assess the efficacy and safety ...
Status
Terminated
Location
Multiple Locations
Start Date
2013-10-22
Trial ID
NCT01852110
The purpose of this study is to determine the safety and effects of rivasti...
Status
Completed
Location
Michael E. DeBakey Veterans Affairs Medical Center
Start Date
2009-01
Trial ID
NCT01030692
Treatments Being Tested
This is a prospective, multicenter, open-label study. Following screening a...
Status
Completed
Location
Département de Gérontologie Clinique
Start Date
2003-11
Trial ID
NCT00234637
Treatments Being Tested
Background and objectives: The aims of this naturalistic study were: to ana...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT02187276
Treatments Being Tested
There are few pharmacological treatments available for Alzheimer's disease,...
Status
Completed
Location
North York General Hospital
Start Date
2010-07
Trial ID
NCT02035982
Treatments Being Tested
to show that 1. patients improve and stabilize after 12 -24 week treatment...
Status
Unknown
Location
University of Tuebingen
Start Date
2008-02
Trial ID
NCT00522015
Treatments Being Tested
The purpose of this study is to provide long-term safety data for rivastigm...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-01
Trial ID
NCT00623103
Treatments Being Tested